| CASE REPORT |
|
| Year : 2021 | Volume
: 5
| Issue : 1 | Page : 38-39 |
|
|
Ropivacaine 0.75% for peribulbar block in vitrectomy
Tjokorda Gde Agung Senapathi1, I Made Gede Widnyana1, Christopher Ryalino1, Ida Bagus Gita Dharma Wibawa2
1 Department of Anaesthesiology and Intensive Care, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
2 Department of Anesthesiology, Pain Management and Intensive Care, Sanglah General Hospital, Udayana University, Denpasar, Bali, Indonesia
Correspondence Address:
Dr. Christopher Ryalino
Department of Anaesthesiology and Intensive Care, Faculty of Medicine, Udayana University, Jl. PB Sudirman, Denpasar 80232, Bali
Indonesia
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/BJOA.BJOA_146_20
|
|
|
Increased life expectancy will result in an increased number of elderlies scheduled for surgery. The vitreous undergoes the irreversible process of aging. Anesthesiologists must provide optimal perioperative care for patients posted for vitrectomy. Peribulbar block is one of the safest alternatives. Ropivacaine has a vasoconstriction effect that useful to minimize the increasing of intraocular pressure (IOP) after peribulbar injection. In this case report, we managed an 86-year-old patient who underwent vitrectomy procedure by peribulbar block. Peribulbar block provides blocks for ciliary, oculomotor, and abducens nerves. The needle is introduced into the extraconal space. The first injection is inferior and temporal, and the second injection is superior and nasal, between the medial third and lateral two-thirds of the orbital roof. The block provided adequate analgesia, akinesia, and decreased IOP.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
